Hims & Hers Health Inc (HIMS) Receives Overweight Rating from Barclays
Barclays initiates coverage on Hims & Hers Health Inc with an Overweight rating.
Hims & Hers Health, Inc. operates a telehealth consultation platform. The company is headquartered in San Francisco, California and currently employs 1,637 full-time employees. The company went IPO on 2019-09-09. Its platform includes access to a provider network, a clinically focused electronic medical record system, digital prescriptions, cloud pharmacy fulfillment, and personalization capabilities. Its digital platform enables access to treatments for a range of chronic conditions, including those related to sexual health, hair loss, dermatology, mental health, and weight loss. The company connects patients to licensed healthcare professionals who can prescribe medications when appropriate and prescriptions are fulfilled online through licensed pharmacies on a subscription basis. The company also offers access to a range of health and wellness products designed to meet individual needs, which can include curated prescription and non-prescription products. Through its mobile applications, consumers can access a range of educational programs, wellness content, and other services.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Hims & Hers Health Inc.
Last Updated: Dec 11, 2025, 11:32 PM · Source: Finnhub.io
Barclays initiates coverage on Hims & Hers Health Inc with an Overweight rating.
Keybanc initiates coverage on Hims & Hers Health Inc with a Sector Weight rating.
Insider Boughton Soleil sold 155,856 shares of Hims & Hers Health Inc.